Pacific Biosciences Of California Price to Sales Ratio 2010-2024 | PACB
Historical PS ratio values for Pacific Biosciences Of California (PACB) over the last 10 years. The current P/S ratio for Pacific Biosciences Of California as of January 30, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Pacific Biosciences Of California P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-01-30 | 1.60 | 2.45 | |
| 2024-09-30 | 1.70 | $0.65 | 2.60 |
| 2024-06-30 | 1.37 | $0.72 | 1.89 |
| 2024-03-31 | 3.75 | $0.78 | 4.79 |
| 2023-12-31 | 9.81 | $0.80 | 12.27 |
| 2023-09-30 | 8.35 | $0.69 | 12.08 |
| 2023-06-30 | 13.30 | $0.62 | 21.58 |
| 2023-03-31 | 11.58 | $0.58 | 19.83 |
| 2022-12-31 | 8.18 | $0.57 | 14.29 |
| 2022-09-30 | 5.81 | $0.63 | 9.26 |
| 2022-06-30 | 4.42 | $0.65 | 6.84 |
| 2022-03-31 | 9.10 | $0.64 | 14.17 |
| 2021-12-31 | 20.46 | $0.64 | 31.89 |
| 2021-09-30 | 25.55 | $0.62 | 41.19 |
| 2021-06-30 | 34.97 | $0.57 | 61.09 |
| 2021-03-31 | 33.31 | $0.53 | 62.96 |
| 2020-12-31 | 25.94 | $0.48 | 54.01 |
| 2020-09-30 | 9.87 | $0.51 | 19.42 |
| 2020-06-30 | 3.45 | $0.54 | 6.42 |
| 2020-03-31 | 3.06 | $0.59 | 5.21 |
| 2019-12-31 | 5.14 | $0.60 | 8.62 |
| 2019-09-30 | 5.16 | $0.56 | 9.26 |
| 2019-06-30 | 6.05 | $0.55 | 11.03 |
| 2019-03-31 | 7.23 | $0.55 | 13.12 |
| 2018-12-31 | 7.40 | $0.60 | 12.35 |
| 2018-09-30 | 5.41 | $0.69 | 7.84 |
| 2018-06-30 | 3.55 | $0.76 | 4.67 |
| 2018-03-31 | 2.05 | $0.80 | 2.56 |
| 2017-12-31 | 2.64 | $0.91 | 2.89 |
| 2017-09-30 | 5.25 | $0.97 | 5.43 |
| 2017-06-30 | 3.56 | $1.04 | 3.44 |
| 2017-03-31 | 5.17 | $1.06 | 4.86 |
| 2016-12-31 | 3.80 | $1.03 | 3.71 |
| 2016-09-30 | 8.96 | $1.22 | 7.36 |
| 2016-06-30 | 7.04 | $1.12 | 6.30 |
| 2016-03-31 | 8.50 | $1.22 | 6.99 |
| 2015-12-31 | 13.13 | $1.22 | 10.72 |
| 2015-09-30 | 3.66 | $0.98 | 3.72 |
| 2015-06-30 | 5.76 | $1.10 | 5.22 |
| 2015-03-31 | 5.84 | $0.93 | 6.27 |
| 2014-12-31 | 7.84 | $0.86 | 9.06 |
| 2014-09-30 | 4.91 | $0.77 | 6.37 |
| 2014-06-30 | 6.18 | $0.59 | 10.43 |
| 2014-03-31 | 5.35 | $0.53 | 10.13 |
| 2013-12-31 | 5.23 | $0.45 | 11.53 |
| 2013-09-30 | 5.52 | $0.41 | 13.35 |
| 2013-06-30 | 2.53 | $0.35 | 7.23 |
| 2013-03-31 | 2.49 | $0.38 | 6.50 |
| 2012-12-31 | 1.70 | $0.47 | 3.63 |
| 2012-09-30 | 1.83 | $0.59 | 3.08 |
| 2012-06-30 | 2.17 | $0.74 | 2.94 |
| 2012-03-31 | 3.42 | $0.81 | 4.25 |
| 2011-12-31 | 2.80 | $0.63 | 4.45 |
| 2011-09-30 | 3.21 | $0.43 | 7.53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.427B | $0.201B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.348B | 26.52 |
| Intuitive Surgical (ISRG) | United States | $203.988B | 93.58 |
| Alcon (ALC) | Switzerland | $45.073B | 30.16 |
| Edwards Lifesciences (EW) | United States | $41.952B | 26.64 |
| IQVIA Holdings (IQV) | United States | $35.950B | 19.81 |
| IDEXX Laboratories (IDXX) | United States | $34.289B | 40.38 |
| DexCom (DXCM) | United States | $33.759B | 50.84 |
| Waters (WAT) | United States | $23.998B | 35.49 |
| STERIS (STE) | Ireland | $21.743B | 25.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.798B | 0.00 |
| Hologic (HOLX) | United States | $16.119B | 17.50 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.577B | 14.96 |
| Globus Medical (GMED) | United States | $12.635B | 32.00 |
| Sysmex ADR (SSMXY) | Japan | $12.243B | 38.39 |
| Penumbra (PEN) | United States | $10.352B | 101.40 |
| Masimo (MASI) | United States | $9.509B | 46.01 |
| Glaukos (GKOS) | United States | $8.767B | 0.00 |
| Teleflex (TFX) | United States | $8.387B | 13.38 |
| Integer Holdings (ITGR) | United States | $4.804B | 27.23 |
| Inari Medical (NARI) | United States | $4.666B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.807B | 0.00 |
| Veracyte (VCYT) | United States | $3.444B | 103.35 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 15.90 |
| Nihon Kohden (NHNKY) | Japan | $2.554B | 19.40 |
| Tandem Diabetes Care (TNDM) | United States | $2.388B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.309B | 20.76 |
| TransMedics (TMDX) | United States | $2.199B | 69.71 |
| Integra LifeSciences Holdings (IART) | United States | $2.016B | 10.53 |
| Alphatec Holdings (ATEC) | United States | $1.710B | 0.00 |
| Artivion (AORT) | United States | $1.309B | 86.72 |
| RxSight (RXST) | United States | $1.273B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.214B | 0.00 |
| Paragon 28 (FNA) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.024B | 0.00 |
| AxoGen (AXGN) | United States | $0.806B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.795B | 13.51 |
| IRadimed (IRMD) | United States | $0.759B | 40.99 |
| Mesa Laboratories (MLAB) | United States | $0.743B | 17.51 |
| SiBone (SIBN) | United States | $0.722B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.715B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.649B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.602B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.504B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.500B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.491B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 25.41 |
| NeuroPace (NPCE) | United States | $0.438B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.429B | 23.23 |
| CVRx (CVRX) | United States | $0.409B | 0.00 |
| Inogen (INGN) | United States | $0.298B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.255B | 0.00 |
| Accuray (ARAY) | United States | $0.223B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| Nevro (NVRO) | United States | $0.190B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.129B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 11.75 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| 908 Devices (MASS) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | Israel | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.86 |
| EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.036B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |